A

Annovis Bio
D

ANVS

2.41000
USD
0.01
(0.42%)
مغلق
حجم التداول
7,181
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
46,961,817
أصول ذات صلة
ALNY
ALNY
-4.39
(-1.33%)
325.26 USD
A
ASND
1.325
(0.77%)
174.320 USD
C
CRBP
-0.15750
(-2.03%)
7.60000 USD
E
EYPT
0.06000
(0.62%)
9.70000 USD
V
VKTX
0.430
(1.55%)
28.150 USD
المزيد
الأخبار المقالات

العنوان: Annovis Bio

القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.